You are here: Home » News-CM » Companies » News
Business Standard

Aleor Dermaceuticals receives USFDA approval for Clobetasol Propionate Shampoo

Health Medical Pharma

Capital Market 

Alembic Pharmaceuticals announced that its JV, Aleor Dermaceuticals has received US Food and Drug Administration (USFDA) Approval for Clobetasol Propionate Shampoo, 0.05%.

The approved AN DA is therapeutically equivalent to the reference listed drug product (RLD), Clobex Shampoo, 0.05%, of Galderma Laboratories, L.

P. (Galderma). Clobetasol Propionate Shampoo, 0.05% is indicated for the treatment of moderate to severe forms of scalp psoriasis in subjects 18 years of age and older.

Clobetasol Propionate Shampoo, 0.05%, has an estimated market size of US$ 28 million for twelve months ending December 2019 according to IQVIA.

Alembic has a cumulative total of 122 ANDA approvals (109 final approvals and 13 tentative approvals) from USFDA.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, May 19 2020. 13:43 IST